Prevora, the only preventive treatment of adult root caries approved by Health Canada, is now being marketed in Canada.
The rollout of this new, in-office prescription antibacterial tooth coating is being handled by a strategic marketing partnership between CHX Technologies, a dental pharmaceutical company and developer of Prevora, and Germiphene, a national manufacturer and distributor of branded fluoride and infection control products for the dental office, the companies announced.
As part of the product launch, CHX will provide marketing activities and professional education services, including an ongoing series of webinars for dental offices. Germiphene will provide customer service, product fulfillment, sales, and an ongoing presence for Prevora at major dental conferences and meetings.
Prevora has been approved in Ireland for reducing cavities in adolescents and adults, and is expected to be approved in the U.K. in mid-2009, according to the companies. In the U.S., Prevora is in the final stages of phase III clinical trials. The results of these trials are expected in late 2009 or early 2010.
Copyright © 2009 DrBicuspid.com
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
